The global “Antiplatelet Drugs Market: Opportunity Analysis and Future Assessment 2022-2030” issued by Reports and Insights provides authentic and first-hand data, qualitative and quantitative analysis by industry analysts, and inputs from industry experts and stakeholders across the entire chain. The research examines current market trends, macroeconomic factors, regional analysis in-depth, as well as market attractiveness by segment. The market research provides SWOT analysis of competitors comprising extraneous environment assessment and PEST study. In addition, the market analysis offers business approaches for handling with COVID-19 impact on the market.
The global antiplatelet drugs market in 2022 is estimated for more than US$ 1.7 Bn and expected to reach a value of US$ 2.4 Bn by 2030 with a significant CAGR of 7.6%.
Request a Sample Copy of the Report for COVID-19 Impact Analysis on Antiplatelet Drugs Market: https://reportsandinsights.com/sample-request/1287
Antiplatelet Drugs Introduction
Antiplatelet drugs are endorsed to people with a background marked by heart attacks and these medications help in decreasing reoccurrence of heart attacks. A portion of the antiplatelet drugs incorporate, ibuprofen, clopidogrel, prasugrel, and ticagrelor. Aspirin is suggested for all patients with Acute Coronary Syndrome (ACS), in the absence of hypersensitivity. It is prescribed alongside one of the oral antiplatelet agents including Clopidogrel, Prasugrel, and Ticagrelor. Prasugrel is prescribed for patients experiencing ACS and for those experiencing Percutaneous Coronary Intervention (PCI). Clopidogrel and Ticagrelor help in anticipating atherothrombotic events in adult patients with ACS, and the individuals who are treated with Coronary Artery Bypass Grafting (CABG) or PCI.
Antiplatelet Drugs Market Dynamics
Increasing prevalence of cardiovascular issue, developing geriatric populace, and stationary way of life are a portion of the main considerations driving the global antiplatelet drugs market development? Cardiovascular diseases are the central reason for death in the developed and developing economies around the globe. As per a report by Centers for Disease Control and Prevention (CDC), 2015, around 800,000 individuals in the U.S. die yearly because of stroke and other cardiovascular diseases. A portion of the normal cardiovascular sicknesses incorporate, rheumatic coronary illness, hypertensive coronary illness, incendiary coronary illness, ischemic coronary illness, and cerebrovascular coronary illness.
View Complete TOC and Figures & Graphs of Antiplatelet Drugs Market Industry Report – https://reportsandinsights.com/report/global-antiplatelet-drugs-market
Antiplatelet Drugs Market Segmentation
The antiplatelet drugs market is segmented on the basis of drug type, application, end user, and by region.
By Drug Type
- Aspirin
- Clopidogrel
- Ticagrelor
- Prasugrel
- Dipyridamole
- Ticlopidine
- Abciximab
- Tirofiban
- Others
By Application
- Myocardial Infraction
- Percutaneous Coronary Interventions
- Angioplasty
- Arterial Thrombosis
- Dental surgeries
- Others
By End User
- Hospitals
- Clinic
- Emergency Service Centers
- Ambulatory Surgical Centers
- Others
Antiplatelet Drugs Market Key Players
Some of the key participating players in antiplatelet drugs market are
- AstraZeneca Inc.
- The Medicines Company
- Portola Pharmaceuticals, Inc.
- Bayer Pharmaceuticals
- Bristol-Myers Squibb Company
- Boehringer Ingelheim Pharmaceuticals Inc.
- Altimed Pharma Inc.
- Dominion Pharmacal
- Alta Laboratories Ltd.
- Novacap
- Shandong Xinhua Pharmaceutical
- Nanjing Pharmaceutical Factory
- Sanis Health Inc.
- Syntex Inc.
- Hoffmann La Roche
- Teva Pharmaceutical
- Sandoz Canada Incorporated
- Pharmascience Inc.
- Nu Pharm Inc.
- Mylan Pharmaceuticals
To view Top Players, Segmentation and other Statistics of Antiplatelet Drugs Industry, Get Sample Report: @ https://reportsandinsights.com/sample-request/1287
About Reports and Insights:
Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Neil Jonathan
1820 Avenue M, Brooklyn
NY 11230, United States
+1-(718) 312-8686
Find Us on Linkedin: www.linkedin.com/company/report-and-insights/